Testing a new pneumonia vaccine for babies 2-23 months old
Treatments studied
Part of Infections clinical trials.
This study tests a new pneumococcal vaccine (PCV24) for babies ages 2 to 23 months. It aims to see if the vaccine is safe and helps protect against serious infections like pneumonia and meningitis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby is 2 to 23 months old and generally healthy.
- Your baby has not had a pneumococcal vaccine before (like Prevnar or Pneumovax).
- Your baby has no severe allergies to vaccines or their ingredients.
- For babies under 12 months: not born early (before 37 weeks) and not low birth weight (under 5.5 pounds).
- Your baby does not have a chronic illness like heart disease, severe anemia, or immune problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new pneumococcal vaccine (PCV24) in healthy infants and children. It aims to protect against serious infections like pneumonia and meningitis caused by pneumococcal bacteria.
This trial tests a 13-valent pneumococcal conjugate vaccine to prevent pneumonia and serious infections caused by pneumococcus bacteria. It may be a good option if your child has never had a pneumococcal vaccine before.
This study tests a pneumococcal vaccine (PCV13) in healthy 2-month-old babies to see if it is safe and helps protect against pneumococcal infections. Your baby would receive the vaccine and be monitored for any side effects.
This study tests a new vaccine that protects against 21 types of bacteria that cause pneumonia and other infections. It is for healthy infants around 2 months old to see if it works as well as the current vaccine.
This study tests an investigational vaccine that may protect infants against infections caused by a bacteria called Streptococcus pneumoniae, which can cause pneumonia and other serious illnesses. The vaccine is given to healthy babies around 2 months old, and the study will see how well it works and how safe it is.
This trial tests a new vaccine designed to protect against 24 types of pneumococcal bacteria (which cause pneumonia and other serious infections). Researchers are checking if it's safe and how well it works in infants, children, and adults.
Hear when a new Pneumococcal Infectious Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.